Investment
Features
FeesSafety
Academy
More
Pluang+

Onterris Q2 revenue misses estimates, shares drop 18%, securities probe launched.

Market News
19 Aug 2026
PRNewsWire
View Source
Bearish
pluang ai news

Onterris reported Q2 revenue of $186.7 million, down 20.4% year-over-year and 6-7% below analyst expectations, causing shares to fall about 18% on August 5, 2026. The company also lowered its full-year 2026 revenue guidance to $740-$790 million from $840-$900 million. Following the disappointing results, Levi & Korsinsky law firm initiated an investigation into potential securities law violations related to Onterris' business outlook and revenue disclosures. Investors who suffered losses are encouraged to contact the firm for a free case evaluation.

More News

Abercrombie & Fitch price target raised to $118; Raymond James downgrades to Market Perform.

Abercrombie & Fitch price target raised to $118; Raymond James downgrades to Market Perform.

Telsey Advisory Group raised Abercrombie & Fitch's price target from $115 to $118, implying an 11.35% upside from the current share price of around $106. Meanwhile, Raymond James downgraded the stock from "Outperform" to "Market Perform," signaling e...

Analyst Insights
Neutral
1 hour ago
Barclays keeps 'Underweight' on Target despite raising price target to $140 amid strong Q2 results.

Barclays keeps 'Underweight' on Target despite raising price target to $140 amid strong Q2 results.

Barclays maintained an "Underweight" rating on Target's stock but raised its price target from $115 to $140, even though Target's shares trade above $161. This cautious stance reflects concerns that Target may underperform its peers despite a strong ...

Analyst Insights
Neutral
1 hour ago
Sea Limited director sells 20,000 shares worth $2.4 million

Sea Limited director sells 20,000 shares worth $2.4 million

Heng Chen Seng, a director at Sea Limited, sold 20,000 shares valued at $2.4 million. This insider sale may indicate personal portfolio adjustments but does not necessarily reflect company performance. Investors should monitor further insider activit...

Market News
Bearish
1 hour ago
Moderna shares soar over 160% after positive Phase 3 melanoma vaccine trial results

Moderna shares soar over 160% after positive Phase 3 melanoma vaccine trial results

Moderna and Merck announced successful Phase 3 trial results for their personalized mRNA melanoma vaccine combined with Keytruda, showing significant improvement in recurrence-free and distant metastasis-free survival. This marks the first positive l...

Market News
Bullish
2 hours ago
Full Truck Alliance posts strong Q2 with 4.4% revenue growth and EPS beating estimates.

Full Truck Alliance posts strong Q2 with 4.4% revenue growth and EPS beating estimates.

Full Truck Alliance reported a strong second quarter with earnings per share of $0.20, beating analyst expectations by 5.26%. The company saw a 4.4% increase in total net revenues to $498.4 million, driven by a 33.1% rise in transaction service reven...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App